Ceftriaxone
NDC Package 68330-005-10
Package Information
Ceftriaxone is used to treat a wide variety of bacterial infections. Marketed by Cephazone Pharma Llc, this product is identified by NDC 68330-005 and is authorized under FDA application ANDA065294.
Identification & Billing
- RxCUI: 1665005 - cefTRIAXone 500 MG Injection
- RxCUI: 1665005 - ceftriaxone 500 MG Injection
- RxCUI: 1665005 - ceftriaxone 500 MG (as ceftriaxone sodium) Injection
- RxCUI: 1665021 - cefTRIAXone 1 GM Injection
- RxCUI: 1665021 - ceftriaxone 1000 MG Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68330 - Cephazone Pharma Llc
- 68330-005 - Ceftriaxone
- 68330-005-10 - 10 BOX in 1 CARTON / 1 VIAL, PIGGYBACK in 1 BOX (68330-005-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PIGGYBACK
- 68330-005 - Ceftriaxone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68330-005-10 identifies a specific commercial package of 10 box in 1 carton / 1 vial, piggyback in 1 box (68330-005-01) / 1 injection, powder, for solution in 1 vial, piggyback of Ceftriaxone, labeled by Cephazone Pharma Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cephazone Pharma Llc on July 15, 2008. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Ceftriaxone is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details.
How is this Cephazone Pharma Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68330000510. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.